| NCT03282682 |
Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male |
https://ClinicalTrials.gov/show/NCT03282682 |
Completed |
Comenius University |
2019-05-30 |
| NCT03242408 |
Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) |
https://ClinicalTrials.gov/show/NCT03242408 |
Completed |
Lipocine Inc. |
2017-05-31 |
| NCT03203681 |
Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters |
https://ClinicalTrials.gov/show/NCT03203681 |
Completed |
University of Miami |
2020-06-01 |
| NCT03126656 |
Effects of Testosterone on Myocardial Repolarization |
https://ClinicalTrials.gov/show/NCT03126656 |
Completed |
University of Roma La Sapienza |
2017-04-30 |
| NCT03091348 |
Subcutaneous vs. Intramuscular Testosterone |
https://ClinicalTrials.gov/show/NCT03091348 |
Completed |
Men’s Health Boston |
2017-11-21 |
| NCT03057899 |
Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS |
https://ClinicalTrials.gov/show/NCT03057899 |
Completed |
Pusan National University Hospital |
2015-11-30 |
| NCT02966652 |
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism |
https://ClinicalTrials.gov/show/NCT02966652 |
Completed |
Diurnal Limited |
2018-10-04 |
| NCT02959853 |
Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot) |
https://ClinicalTrials.gov/show/NCT02959853 |
Completed |
Baylor College of Medicine |
2018-11-20 |
| NCT02956447 |
Administration of Kisspeptin in Patients With Hyperprolactinemia |
https://ClinicalTrials.gov/show/NCT02956447 |
Recruiting |
Massachusetts General Hospital |
2022-03-31 |
| NCT02953834 |
Kisspeptin Influence on Glucose Homeostasis |
https://ClinicalTrials.gov/show/NCT02953834 |
Recruiting |
Massachusetts General Hospital |
2022-12-31 |
| NCT02937740 |
Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natestoâ„¢ |
https://ClinicalTrials.gov/show/NCT02937740 |
Completed |
Acerus Pharmaceuticals Corporation |
2017-10-31 |
| NCT02921386 |
The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate |
https://ClinicalTrials.gov/show/NCT02921386 |
Completed |
Clarus Therapeutics, Inc. |
2017-01-21 |
| NCT02908074 |
A 6 Month Safety Extension Study of MBGS205 |
https://ClinicalTrials.gov/show/NCT02908074 |
Completed |
Mereo BioPharma |
2018-09-08 |
| NCT02847806 |
Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man |
https://ClinicalTrials.gov/show/NCT02847806 |
Completed |
University Hospital, Caen |
2015-12-31 |
| NCT02777242 |
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism |
https://ClinicalTrials.gov/show/NCT02777242 |
Completed |
Antares Pharma Inc. |
2016-08-31 |
| NCT02758431 |
Cardiovascular Outcomes of Low Testosterone |
https://ClinicalTrials.gov/show/NCT02758431 |
Recruiting |
University of Colorado, Denver |
2021-01-31 |
| NCT02748005 |
Evaluation of Furosap in Human Volunteers |
https://ClinicalTrials.gov/show/NCT02748005 |
Completed |
Chemical Resources |
2015-07-31 |
| NCT02733133 |
Product Transference Study of Testagen™ TDS®-Testosterone |
https://ClinicalTrials.gov/show/NCT02733133 |
Enrolling by invitation |
Transdermal Delivery Solutions Corp |
2020-10-31 |
| NCT02730169 |
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism |
https://ClinicalTrials.gov/show/NCT02730169 |
Completed |
Mereo BioPharma |
2018-02-15 |
| NCT02722278 |
A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT02722278 |
Completed |
Clarus Therapeutics, Inc. |
2016-11-30 |
| NCT02702882 |
The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans. |
https://ClinicalTrials.gov/show/NCT02702882 |
Completed |
Chemical Resources |
2017-03-31 |
| NCT02697188 |
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT02697188 |
Completed |
Clarus Therapeutics, Inc. |
2008-04-30 |
| NCT02672592 |
Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT02672592 |
Completed |
University Hospital, Basel, Switzerland |
2017-06-30 |
| NCT02670343 |
Phlebotomy Study of Testosterone Undecanoate |
https://ClinicalTrials.gov/show/NCT02670343 |
Completed |
Clarus Therapeutics, Inc. |
2016-03-31 |
| NCT02653092 |
Reprometabolic Syndrome Mediates Subfertility in Obesity |
https://ClinicalTrials.gov/show/NCT02653092 |
Recruiting |
University of Colorado, Denver |
2020-02-29 |
| NCT02651688 |
A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene |
https://ClinicalTrials.gov/show/NCT02651688 |
Completed |
Repros Therapeutics Inc. |
2017-05-02 |
| NCT02514629 |
Testosterone, Metformin, or Both, for Hypogonadism in Obese Males |
https://ClinicalTrials.gov/show/NCT02514629 |
Completed |
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
2016-07-12 |
| NCT02504541 |
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism |
https://ClinicalTrials.gov/show/NCT02504541 |
Completed |
Antares Pharma Inc. |
2016-06-30 |
| NCT02380755 |
Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism |
https://ClinicalTrials.gov/show/NCT02380755 |
Completed |
University of Sao Paulo |
2017-01-31 |
| NCT02367105 |
Lifestyle Intervention and Testosterone Replacement in Obese Seniors |
https://ClinicalTrials.gov/show/NCT02367105 |
Completed |
VA Office of Research and Development |
2019-07-31 |
| NCT02366975 |
TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST |
https://ClinicalTrials.gov/show/NCT02366975 |
Completed |
University of Florence |
2017-01-31 |
| NCT02274181 |
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration |
https://ClinicalTrials.gov/show/NCT02274181 |
Completed |
Repros Therapeutics Inc. |
2015-01-31 |
| NCT02248701 |
Testosterone Plus Finasteride Treatment After Spinal Cord Injury |
https://ClinicalTrials.gov/show/NCT02248701 |
Recruiting |
VA Office of Research and Development |
2021-05-31 |
| NCT02233751 |
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate |
https://ClinicalTrials.gov/show/NCT02233751 |
Completed |
Antares Pharma Inc. |
2014-10-31 |
| NCT02222558 |
Oral Testosterone for the Treatment of Hypogonadism in Males |
https://ClinicalTrials.gov/show/NCT02222558 |
Completed |
TesoRx Pharma, LLC |
2015-04-30 |
| NCT02171390 |
Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy |
https://ClinicalTrials.gov/show/NCT02171390 |
Completed |
Gulhane School of Medicine |
2012-06-30 |
| NCT02159469 |
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism |
https://ClinicalTrials.gov/show/NCT02159469 |
Completed |
Antares Pharma Inc. |
2015-02-28 |
| NCT02154477 |
Effect of Intranasal Insulin on LH Concentrations in Man |
https://ClinicalTrials.gov/show/NCT02154477 |
Completed |
Texas Tech University Health Sciences Center |
2017-12-31 |
| NCT02149264 |
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males |
https://ClinicalTrials.gov/show/NCT02149264 |
Completed |
Ferring Pharmaceuticals |
2015-05-31 |
| NCT02137265 |
Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism |
https://ClinicalTrials.gov/show/NCT02137265 |
Recruiting |
University of Illinois at Chicago |
2019-10-31 |
| NCT02111473 |
The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism |
https://ClinicalTrials.gov/show/NCT02111473 |
Completed |
Gulhane School of Medicine |
2012-05-31 |
| NCT02111434 |
Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment |
https://ClinicalTrials.gov/show/NCT02111434 |
Completed |
Gulhane School of Medicine |
2014-04-30 |
| NCT02110368 |
Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT02110368 |
Completed |
Amneal Pharmaceuticals, LLC |
2014-03-31 |
| NCT02102646 |
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism |
https://ClinicalTrials.gov/show/NCT02102646 |
Completed |
Herlev Hospital |
2015-10-31 |
| NCT02081300 |
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism |
https://ClinicalTrials.gov/show/NCT02081300 |
Completed |
Lipocine Inc. |
2015-05-31 |
| NCT01270841 |
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01270841 |
Completed |
Repros Therapeutics Inc. |
2011-12-31 |
| NCT01993225 |
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% |
https://ClinicalTrials.gov/show/NCT01993225 |
Completed |
Repros Therapeutics Inc. |
2014-08-31 |
| NCT01993212 |
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% |
https://ClinicalTrials.gov/show/NCT01993212 |
Completed |
Repros Therapeutics Inc. |
2014-09-30 |
| NCT01976728 |
LutrePulse Hypogonadotropic Hypogonadism |
https://ClinicalTrials.gov/show/NCT01976728 |
Completed |
Ferring Pharmaceuticals |
2018-02-23 |
| NCT01952782 |
Neuropeptides in Human Reproduction |
https://ClinicalTrials.gov/show/NCT01952782 |
Recruiting |
Massachusetts General Hospital |
2022-08-31 |
| NCT01923870 |
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function |
https://ClinicalTrials.gov/show/NCT01923870 |
Completed |
Repros Therapeutics Inc. |
2014-01-31 |
| NCT01923857 |
Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function |
https://ClinicalTrials.gov/show/NCT01923857 |
Completed |
Repros Therapeutics Inc. |
2014-08-31 |
| NCT01919294 |
Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) |
https://ClinicalTrials.gov/show/NCT01919294 |
Completed |
Sheffield Teaching Hospitals NHS Foundation Trust |
2017-01-30 |
| NCT01894308 |
A Dose Ranging Study to Examine Testagen® TDS-Testosterone 5% |
https://ClinicalTrials.gov/show/NCT01894308 |
Enrolling by invitation |
Transdermal Delivery Solutions Corp |
2020-11-30 |
| NCT01893281 |
The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel |
https://ClinicalTrials.gov/show/NCT01893281 |
Completed |
Eli Lilly and Company |
2014-01-31 |
| NCT01887418 |
Pharmacokinetic Study of Testosterone Enanthate |
https://ClinicalTrials.gov/show/NCT01887418 |
Completed |
Antares Pharma Inc. |
2014-01-31 |
| NCT01880086 |
Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration |
https://ClinicalTrials.gov/show/NCT01880086 |
Completed |
Weill Medical College of Cornell University |
2016-03-31 |
| NCT01873989 |
Testosterone Replacement for Male Opioid Agonist Maintained Patients |
https://ClinicalTrials.gov/show/NCT01873989 |
Completed |
Yale University |
2015-01-31 |
| NCT01816295 |
A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy |
https://ClinicalTrials.gov/show/NCT01816295 |
Completed |
Eli Lilly and Company |
2014-10-31 |
| NCT01765179 |
Safety and Efficacy Trial of Testosterone Undecanoate |
https://ClinicalTrials.gov/show/NCT01765179 |
Completed |
Clarus Therapeutics, Inc. |
2013-07-31 |
| NCT01748370 |
Vitamin D Treatment and Hypogonadism in Men |
https://ClinicalTrials.gov/show/NCT01748370 |
Completed |
Medical University of Graz |
2017-11-12 |
| NCT01739595 |
Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01739595 |
Completed |
Repros Therapeutics Inc. |
2013-09-30 |
| NCT01739582 |
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01739582 |
Completed |
Repros Therapeutics Inc. |
2014-04-30 |
| NCT01717768 |
Oral Testosterone for the Treatment of Hypogonadism |
https://ClinicalTrials.gov/show/NCT01717768 |
Completed |
TesoRx Pharma, LLC |
2014-08-31 |
| NCT01709331 |
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) |
https://ClinicalTrials.gov/show/NCT01709331 |
Completed |
Merck Sharp & Dohme Corp. |
2015-04-08 |
| NCT01703741 |
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel |
https://ClinicalTrials.gov/show/NCT01703741 |
Completed |
Ferring Pharmaceuticals |
2013-10-31 |
| NCT01699178 |
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT01699178 |
Completed |
Clarus Therapeutics, Inc. |
2014-04-30 |
| NCT01665599 |
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel |
https://ClinicalTrials.gov/show/NCT01665599 |
Completed |
Ferring Pharmaceuticals |
2013-04-30 |
| NCT01623570 |
Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP |
https://ClinicalTrials.gov/show/NCT01623570 |
Completed |
Centro Riproduzione e Andrologia |
2012-05-31 |
| NCT01619683 |
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01619683 |
Completed |
Repros Therapeutics Inc. |
2014-09-30 |
| NCT01601327 |
Effects of Medications in Patients With Hypogonadism |
https://ClinicalTrials.gov/show/NCT01601327 |
Completed |
Gulhane School of Medicine |
2012-03-31 |
| NCT04320745 |
A Study to Evaluate Androderm’s Effect on Blood Pressure in Adult Hypogonodal Male Participants. |
https://ClinicalTrials.gov/show/NCT04320745 |
Recruiting |
Allergan |
2020-08-27 |
| NCT01534208 |
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01534208 |
Completed |
Repros Therapeutics Inc. |
2013-10-31 |
| NCT01533129 |
The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism |
https://ClinicalTrials.gov/show/NCT01533129 |
Completed |
Gulhane School of Medicine |
2011-04-30 |
| NCT01532414 |
Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01532414 |
Completed |
Repros Therapeutics Inc. |
2013-03-31 |
| NCT01454011 |
The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups |
https://ClinicalTrials.gov/show/NCT01454011 |
Completed |
Gulhane School of Medicine |
2011-02-28 |
| NCT01438073 |
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling |
https://ClinicalTrials.gov/show/NCT01438073 |
Recruiting |
Massachusetts General Hospital |
2023-09-30 |
| NCT01438034 |
Kisspeptin in the Evaluation of Delayed Puberty |
https://ClinicalTrials.gov/show/NCT01438034 |
Recruiting |
Massachusetts General Hospital |
2023-11-30 |
| NCT01446042 |
Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism |
https://ClinicalTrials.gov/show/NCT01446042 |
Completed |
Acerus Pharmaceuticals Corporation |
2012-12-31 |
| NCT01419236 |
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels |
https://ClinicalTrials.gov/show/NCT01419236 |
Completed |
Eli Lilly and Company |
2013-12-31 |
| NCT01403532 |
Sequential Therapy for Hypogonadotropic Hypogonadism |
https://ClinicalTrials.gov/show/NCT01403532 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2012-12-31 |
| NCT01403116 |
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT01403116 |
Completed |
Clarus Therapeutics, Inc. |
2013-09-30 |
| NCT01386606 |
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) |
https://ClinicalTrials.gov/show/NCT01386606 |
Completed |
Repros Therapeutics Inc. |
2011-10-31 |
| NCT01386567 |
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 |
https://ClinicalTrials.gov/show/NCT01386567 |
Completed |
Repros Therapeutics Inc. |
2013-01-31 |
| NCT01378299 |
CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy |
https://ClinicalTrials.gov/show/NCT01378299 |
Completed |
VA Office of Research and Development |
2016-11-07 |
| NCT01370369 |
Efficacy, Pharmacokinetics and Safety of Testosterone |
https://ClinicalTrials.gov/show/NCT01370369 |
Completed |
Ferring Pharmaceuticals |
2011-07-31 |
| NCT01323140 |
Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems |
https://ClinicalTrials.gov/show/NCT01323140 |
Completed |
Watson Pharmaceuticals |
2011-07-31 |
| NCT04274894 |
A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism |
https://ClinicalTrials.gov/show/NCT04274894 |
Recruiting |
AbbVie |
2020-12-17 |
| NCT04049331 |
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone |
https://ClinicalTrials.gov/show/NCT04049331 |
Recruiting |
Seattle Institute for Biomedical and Clinical Research |
2024-12-01 |
| NCT03245827 |
Hypogonadotropic Hypogonadism in Obese Young Males |
https://ClinicalTrials.gov/show/NCT03245827 |
Recruiting |
St. Louis University |
2021-12-31 |
| NCT03933618 |
Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function |
https://ClinicalTrials.gov/show/NCT03933618 |
Completed |
Albany Medical College |
2017-03-08 |
| NCT03887936 |
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism |
https://ClinicalTrials.gov/show/NCT03887936 |
Recruiting |
VA Office of Research and Development |
2024-09-30 |
| NCT03868059 |
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT03868059 |
Completed |
Lipocine Inc. |
2019-02-19 |
| NCT03792477 |
A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males |
https://ClinicalTrials.gov/show/NCT03792477 |
Completed |
Pfizer |
2020-04-02 |
| NCT03792321 |
Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2) |
https://ClinicalTrials.gov/show/NCT03792321 |
Completed |
University Medical Centre Ljubljana |
2015-03-05 |
| NCT03687606 |
Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) |
https://ClinicalTrials.gov/show/NCT03687606 |
Recruiting |
Tongji Hospital |
2024-10-01 |
| NCT03619330 |
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. |
https://ClinicalTrials.gov/show/NCT03619330 |
Completed |
University Medical Centre Ljubljana |
2015-08-31 |
| NCT03541395 |
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males |
https://ClinicalTrials.gov/show/NCT03541395 |
Completed |
Lund University |
2015-06-30 |
| NCT03518034 |
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT03518034 |
Recruiting |
AbbVie |
2022-06-30 |
| NCT04456296 |
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism |
https://ClinicalTrials.gov/show/NCT04456296 |
Recruiting |
Endo Pharmaceuticals |
2022-04-30 |
| NCT03490513 |
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism |
https://ClinicalTrials.gov/show/NCT03490513 |
Recruiting |
Baylor College of Medicine |
2023-04-14 |
| NCT03418896 |
Extragonadal Effects of hCG on Calcium Homeostasis |
https://ClinicalTrials.gov/show/NCT03418896 |
Active, not recruiting |
Rigshospitalet, Denmark |
2020-10-31 |
| NCT01252745 |
Efficacy of an Intranasal Testosterone Product |
https://ClinicalTrials.gov/show/NCT01252745 |
Completed |
Acerus Pharmaceuticals Corporation |
2010-11-30 |
| NCT01228071 |
Time to Eugonadal Range, Time to Steady State and Drying Time |
https://ClinicalTrials.gov/show/NCT01228071 |
Completed |
Endo Pharmaceuticals |
2011-05-31 |
| NCT01206270 |
Androgen for Leydig Cell Proliferation |
https://ClinicalTrials.gov/show/NCT01206270 |
Completed |
University of Roma La Sapienza |
2017-06-30 |
| NCT01191320 |
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01191320 |
Completed |
Repros Therapeutics Inc. |
2011-12-31 |
| NCT01160341 |
Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism |
https://ClinicalTrials.gov/show/NCT01160341 |
Completed |
Gulhane School of Medicine |
2010-01-31 |
| NCT01133548 |
Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males |
https://ClinicalTrials.gov/show/NCT01133548 |
Completed |
AbbVie |
2010-07-31 |
| NCT01127659 |
Testosterone Replacement in Men With Diabetes and Obesity |
https://ClinicalTrials.gov/show/NCT01127659 |
Completed |
University at Buffalo |
2015-03-31 |
| NCT01123278 |
Testosterone Replacement in Metabolic Syndrome and Inflammation |
https://ClinicalTrials.gov/show/NCT01123278 |
Completed |
University of Roma La Sapienza |
2014-10-31 |
| NCT01107067 |
Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism |
https://ClinicalTrials.gov/show/NCT01107067 |
Completed |
Gulhane School of Medicine |
2009-12-31 |
| NCT01104246 |
Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT01104246 |
Completed |
Watson Pharmaceuticals |
2010-09-30 |
| NCT01084265 |
A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism |
https://ClinicalTrials.gov/show/NCT01084265 |
Completed |
Merck KGaA, Darmstadt, Germany |
2005-12-31 |
| NCT01067365 |
Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT01067365 |
Completed |
Repros Therapeutics Inc. |
2007-05-31 |
| NCT01061970 |
Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy |
https://ClinicalTrials.gov/show/NCT01061970 |
Completed |
QuatRx Pharmaceuticals Company |
NA |
| NCT00998933 |
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure |
https://ClinicalTrials.gov/show/NCT00998933 |
Completed |
Solvay Pharmaceuticals |
2009-10-31 |
| NCT00975650 |
Efficacy and Tolerability of an Intra-Nasal Testosterone Product |
https://ClinicalTrials.gov/show/NCT00975650 |
Completed |
Acerus Pharmaceuticals Corporation |
2010-05-31 |
| NCT00962637 |
Study to Evaluate the Safety and Efficacy of Androxalâ„¢ Treatment in Men With Secondary Hypogonadism |
https://ClinicalTrials.gov/show/NCT00962637 |
Completed |
Repros Therapeutics Inc. |
2007-05-31 |
| NCT00957528 |
Cycled Testosterone Replacement Study |
https://ClinicalTrials.gov/show/NCT00957528 |
Completed |
The University of Texas Medical Branch, Galveston |
2008-12-31 |
| NCT00924612 |
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation |
https://ClinicalTrials.gov/show/NCT00924612 |
Completed |
Clarus Therapeutics, Inc. |
2009-09-30 |
| NCT00914823 |
Administration of Kisspeptin to Subjects With Reproductive Disorders |
https://ClinicalTrials.gov/show/NCT00914823 |
Recruiting |
Massachusetts General Hospital |
2023-12-31 |
| NCT00911586 |
Pharmacokinetic Study to Determine Time to Steady-state |
https://ClinicalTrials.gov/show/NCT00911586 |
Completed |
Clarus Therapeutics, Inc. |
2009-09-30 |
| NCT00857961 |
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations |
https://ClinicalTrials.gov/show/NCT00857961 |
Completed |
Eli Lilly and Company |
2008-01-31 |
| NCT00857454 |
A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations |
https://ClinicalTrials.gov/show/NCT00857454 |
Completed |
Eli Lilly and Company |
2009-08-31 |
| NCT00857168 |
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion |
https://ClinicalTrials.gov/show/NCT00857168 |
Completed |
Acrux DDS Pty Ltd |
2009-02-28 |
| NCT00837616 |
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism |
https://ClinicalTrials.gov/show/NCT00837616 |
Completed |
Nemours Children’s Clinic |
2012-06-30 |
| NCT03345797 |
Evaluation of Testosterone Nasal Gel in Hypogonadal Boys |
https://ClinicalTrials.gov/show/NCT03345797 |
Recruiting |
Acerus Pharmaceuticals Corporation |
2020-11-30 |
| NCT03973840 |
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes |
https://ClinicalTrials.gov/show/NCT03973840 |
Completed |
Clarus Therapeutics, Inc. |
2018-07-31 |
| NCT01560546 |
Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) |
https://ClinicalTrials.gov/show/NCT01560546 |
Completed |
Odense University Hospital |
2013-05-31 |
| NCT03242590 |
Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). |
https://ClinicalTrials.gov/show/NCT03242590 |
Completed |
Lipocine Inc. |
2017-03-31 |
| NCT03019575 |
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) |
https://ClinicalTrials.gov/show/NCT03019575 |
Completed |
Merck Sharp & Dohme Corp. |
2020-05-05 |
| NCT03198728 |
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT03198728 |
Completed |
Marius Pharmaceuticals |
2020-05-01 |
| NCT00752869 |
Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement |
https://ClinicalTrials.gov/show/NCT00752869 |
Completed |
The Miriam Hospital |
2012-03-31 |
| NCT00706719 |
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone |
https://ClinicalTrials.gov/show/NCT00706719 |
Completed |
Repros Therapeutics Inc. |
2009-07-31 |
| NCT00702650 |
A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations |
https://ClinicalTrials.gov/show/NCT00702650 |
Completed |
Eli Lilly and Company |
2009-07-31 |
| NCT00697814 |
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism |
https://ClinicalTrials.gov/show/NCT00697814 |
Completed |
Federal University of São Paulo |
2005-06-30 |
| NCT00695110 |
Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00695110 |
Completed |
Clarus Therapeutics, Inc. |
2008-12-31 |
| NCT00663793 |
ORAL T-6: Oral Androgens in Man-6 |
https://ClinicalTrials.gov/show/NCT00663793 |
Completed |
University of Washington |
2009-05-31 |
| NCT00647868 |
NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT00647868 |
Completed |
Acerus Pharmaceuticals Corporation |
2009-03-31 |
| NCT00613782 |
Reandron in Diabetic Men Witn Low Testosterone Level |
https://ClinicalTrials.gov/show/NCT00613782 |
Completed |
Austin Health |
2014-01-31 |
| NCT00613288 |
Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism |
https://ClinicalTrials.gov/show/NCT00613288 |
Completed |
University of Aarhus |
2009-09-30 |
| NCT00597051 |
Study of 3 Doses of ARD-0403 in Testosterone Deficient Men |
https://ClinicalTrials.gov/show/NCT00597051 |
Completed |
Ardana Bioscience Ltd |
2006-02-28 |
| NCT00522431 |
A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone |
https://ClinicalTrials.gov/show/NCT00522431 |
Completed |
Endo Pharmaceuticals |
2008-03-31 |
| NCT00504712 |
Testosterone for Peripheral Vascular Disease |
https://ClinicalTrials.gov/show/NCT00504712 |
Completed |
Barnsley Hospital |
2009-12-31 |
| NCT00493961 |
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism |
https://ClinicalTrials.gov/show/NCT00493961 |
Active, not recruiting |
Massachusetts General Hospital |
2022-02-28 |
| NCT00487734 |
Effect of Testosterone Replacement on Insulin Resistance |
https://ClinicalTrials.gov/show/NCT00487734 |
Completed |
McGuire Research Institute |
2010-10-31 |
| NCT00475501 |
5-Alpha Reductase and Anabolic Effects of Testosterone |
https://ClinicalTrials.gov/show/NCT00475501 |
Completed |
VA Office of Research and Development |
2012-03-31 |
| NCT00470990 |
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men |
https://ClinicalTrials.gov/show/NCT00470990 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2008-06-30 |
| NCT00467870 |
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00467870 |
Completed |
Endo Pharmaceuticals |
2009-07-31 |
| NCT00456274 |
Baselines in Reproductive Disorders |
https://ClinicalTrials.gov/show/NCT00456274 |
Recruiting |
Massachusetts General Hospital |
2020-09-30 |
| NCT00452322 |
Safety of Testosterone Undecanoate i.m. in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00452322 |
Completed |
University Hospital Muenster |
NA |
| NCT00448955 |
Open-Label Study of ARD-0403 in Testosterone Deficient Men |
https://ClinicalTrials.gov/show/NCT00448955 |
Completed |
Ardana Bioscience Ltd |
2008-02-29 |
| NCT00434824 |
Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203) |
https://ClinicalTrials.gov/show/NCT00434824 |
Completed |
Merck Sharp & Dohme Corp. |
2004-07-31 |
| NCT00433199 |
Testosterone Treatment for Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00433199 |
Completed |
Abbott |
2007-10-31 |
| NCT00431197 |
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men |
https://ClinicalTrials.gov/show/NCT00431197 |
Completed |
Mayo Clinic |
2007-12-31 |
| NCT00421460 |
The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction |
https://ClinicalTrials.gov/show/NCT00421460 |
Completed |
Chulalongkorn University |
2011-01-31 |
| NCT00415571 |
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors |
https://ClinicalTrials.gov/show/NCT00415571 |
Completed |
QuatRx Pharmaceuticals Company |
NA |
| NCT00400335 |
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride |
https://ClinicalTrials.gov/show/NCT00400335 |
Completed |
GlaxoSmithKline |
NA |
| NCT00398580 |
28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00398580 |
Completed |
GlaxoSmithKline |
2007-10-31 |
| NCT00392912 |
Effect of Testosterone Therapy in Men With Alzheimer’s Disease and Low Testosterone |
https://ClinicalTrials.gov/show/NCT00392912 |
Completed |
VA Medical Center, Houston |
2009-11-30 |
| NCT00392756 |
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) |
https://ClinicalTrials.gov/show/NCT00392756 |
Recruiting |
Massachusetts General Hospital |
2022-02-28 |
| NCT00392457 |
Investigating the Regulation of Reproductive Hormones in Adult Men |
https://ClinicalTrials.gov/show/NCT00392457 |
Completed |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
2007-02-28 |
| NCT00383656 |
Pulsatile GnRH in Anovulatory Infertility |
https://ClinicalTrials.gov/show/NCT00383656 |
Recruiting |
Massachusetts General Hospital |
2020-09-30 |
| NCT00372008 |
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males |
https://ClinicalTrials.gov/show/NCT00372008 |
Completed |
Acrux DDS Pty Ltd |
2007-04-30 |
| NCT00365794 |
Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men |
https://ClinicalTrials.gov/show/NCT00365794 |
Completed |
University of Southern California |
2013-12-31 |
| NCT00351819 |
Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception |
https://ClinicalTrials.gov/show/NCT00351819 |
Completed |
Boston University |
2012-11-30 |
| NCT00349362 |
Testosterone for Men With Insulin Treated Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00349362 |
Completed |
Barnsley Hospital |
2008-10-31 |
| NCT00345969 |
Exercise and Testosterone Therapy in Elderly Men With Physical Frailty |
https://ClinicalTrials.gov/show/NCT00345969 |
Completed |
Washington University School of Medicine |
2009-02-28 |
| NCT00290134 |
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism |
https://ClinicalTrials.gov/show/NCT00290134 |
Completed |
QuatRx Pharmaceuticals Company |
NA |
| NCT00287586 |
Testosterone Replacement in Older Men and Atherosclerosis Progression |
https://ClinicalTrials.gov/show/NCT00287586 |
Completed |
Brigham and Women’s Hospital |
2012-02-07 |
| NCT00266864 |
Testosterone Replacement Therapy in Chronic Spinal Cord Injury |
https://ClinicalTrials.gov/show/NCT00266864 |
Completed |
VA Office of Research and Development |
2012-08-31 |
| NCT00244023 |
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone |
https://ClinicalTrials.gov/show/NCT00244023 |
Completed |
SELARL du Dr Jacques BUVAT |
2007-07-31 |
| NCT00223860 |
Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury. |
https://ClinicalTrials.gov/show/NCT00223860 |
Completed |
VA Office of Research and Development |
2007-12-31 |
| NCT00220298 |
Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism |
https://ClinicalTrials.gov/show/NCT00220298 |
Completed |
Bayer |
2007-10-31 |
| NCT00202462 |
The Effect of Testosterone on Mood and Quality of Life |
https://ClinicalTrials.gov/show/NCT00202462 |
Completed |
Seattle Institute for Biomedical and Clinical Research |
2005-12-31 |
| NCT00194675 |
TRADE-Testosterone Replacement and Dutasteride Effectiveness |
https://ClinicalTrials.gov/show/NCT00194675 |
Completed |
University of Washington |
2010-04-30 |
| NCT00193700 |
Pharmacokinetic Evaluation of Testosterone Gel (1%) |
https://ClinicalTrials.gov/show/NCT00193700 |
Completed |
Solvay Pharmaceuticals |
NA |
| NCT00193661 |
Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism |
https://ClinicalTrials.gov/show/NCT00193661 |
Completed |
Solvay Pharmaceuticals |
2007-03-31 |
| NCT00179517 |
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo |
https://ClinicalTrials.gov/show/NCT00179517 |
Completed |
Beth Israel Deaconess Medical Center |
2008-04-30 |
| NCT00161486 |
The Effects of Testosterone on Prostate Tissue (ACYP-1) |
https://ClinicalTrials.gov/show/NCT00161486 |
Completed |
University of Washington |
2004-11-30 |
| NCT00161421 |
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone |
https://ClinicalTrials.gov/show/NCT00161421 |
Completed |
University of Washington |
2006-07-31 |
| NCT00141492 |
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00141492 |
Completed |
Solvay Pharmaceuticals |
2007-06-30 |
| NCT00140998 |
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome |
https://ClinicalTrials.gov/show/NCT00140998 |
Completed |
Nemours Children’s Clinic |
NA |
| NCT00138710 |
Short-term Effects of Aromatase Inhibition in Obese Men |
https://ClinicalTrials.gov/show/NCT00138710 |
Completed |
Rijnstate Hospital |
2010-01-31 |
| NCT00136695 |
Anastrozole Administration in Elderly Hypogonadal Men |
https://ClinicalTrials.gov/show/NCT00136695 |
Completed |
Massachusetts General Hospital |
2008-10-31 |
| NCT00119483 |
Older Men and Testosterone |
https://ClinicalTrials.gov/show/NCT00119483 |
Completed |
University Hospital of North Norway |
NA |
| NCT00104572 |
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. |
https://ClinicalTrials.gov/show/NCT00104572 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-12-31 |
| NCT00080483 |
Testosterone and Growth Hormone for Bone Loss in Men |
https://ClinicalTrials.gov/show/NCT00080483 |
Completed |
University of Pennsylvania |
2010-09-30 |
| NCT00048841 |
Prevention of Osteoporosis in Men With Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00048841 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00004438 |
Leuprolide in Treating Adults With Hypogonadotropism |
https://ClinicalTrials.gov/show/NCT00004438 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004426 |
Leuprolide in Determining the Cause of Gonadotropin Deficiency |
https://ClinicalTrials.gov/show/NCT00004426 |
Completed |
FDA Office of Orphan Products Development |
NA |